Endoscope co Medigus reports good pre-clinical study
The procedure used a prototype of a new endoscope it developed.
The test's objective was to see if the procedure can be carried out with the new endoscope. According to Medigus, if the technology progresses to a finished product, it can replace existing surgical procedure for sufferers of problems in the middle ear, without the need to perforate the ear drum. Another objective of the test was to examine the first usage of the endoscope.
Medigus will now apply for an ethics (Helsinki) committee authorization for human clinical trials.
Shares in Medigus rose 2.52% by early afternoon to NIS 1.66. The shares rose 20.7% in January.
Published by Globes [online], Israel business news - www.globes-online.com - on February 1, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options